Apeloa Pharmaceutical Co.,Ltd (SHE:000739)

Market Cap	20.49B +8.2%
Revenue (ttm)	10.50B -14.4%
Net Income	861.74M -19.7%
EPS	0.75 -19.0%
Shares Out	1.15B
PE Ratio	23.93
Forward PE	14.27
Dividend	0.35 (1.90%)
Ex-Dividend Date	Sep 17, 2025

Volume	4,924,364
Average Volume	15,076,954
Open	18.98
Previous Close	17.84
Day's Range	17.99 - 18.98
52-Week Range	12.96 - 19.59
Beta	0.34
RSI	51.21
Earnings Date	Mar 20, 2026

About SHE:000739

Apeloa Pharmaceutical Co.,Ltd provides raw materials and intermediates to various pharmaceutical factories in the People’s Republic of China and internationally. It operates through API, CDMO, and Pharmaceutical segments. The company offers API intermediates business, which includes cephalosporin, penicillin, psychotropic, cardiovascular and cerebrovascular, and veterinary API intermediates series; innovative drug R&D and production services CDMO include R&D services, commercial human drug projects, commercial veterinary drug projects and other...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1989
• Employees: 7,060
• Stock Exchange: Shenzhen Stock Exchange
• Ticker Symbol: 000739

Financial Performance

In 2024, SHE:000739's revenue was 12.02 billion, an increase of 4.77% compared to the previous year's 11.47 billion. Earnings were 1.03 billion, a decrease of -2.29%.